Full-Time

Quickcode Solutions Manager

Posted on 10/31/2025

Radformation

Radformation

51-200 employees

FDA-cleared software for radiation therapy planning

Compensation Overview

$210k - $250k/yr

Remote in USA

Remote

Category
Sales & Account Management (1)
Requirements
  • Bachelor’s degree in business, marketing, or a related field
  • Radiation oncology billing expertise (must-have) deep understanding of billing workflows, coding, and department processes
  • Strong technical acumen with complex software tools
  • Highly proficient in CRM software and analytics; Salesforce preferred
  • 3+ years of software sales or equivalent consultative sales experience
  • Proven ability to engage stakeholders and clearly communicate technical and financial value
  • Excellent problem-solving and analytical skills, including the ability to monitor and improve sales performance using CRM tools
  • Ability to work collaboratively across sales, marketing, and product teams while also driving individual performance
Responsibilities
  • Subject Matter Expertise: Serve as the subject matter expert for QuickCode and the unique challenges of radiation oncology billing
  • Subject Matter Expertise: Work directly with prospects and customers to understand billing problems and position QuickCode as the solution
  • Subject Matter Expertise: Lead product demonstrations, facilitate ROI analyses, and support the advancement of deals in partnership with the Account Manager
  • Quota & Sales Process Support: Own a QuickCode quota for your market
  • Quota & Sales Process Support: Partner with the Account Manager on deal strategy while the AM drives the overall sales process
  • Quota & Sales Process Support: Contribute technical positioning, stakeholder education, and proof-of-value steps to help move opportunities forward
  • Quota & Sales Process Support: Keep opportunities and activities accurately updated in Salesforce
  • Sales & Pipeline Development: Collaborate with the Account Manager to build and maintain a strong QuickCode pipeline
  • Sales & Pipeline Development: Generate new opportunities when needed to support territory growth, engaging in prospecting as market needs require
  • Sales & Pipeline Development: Use a consultative sales approach to connect QuickCode’s value to customer needs
  • Post-Sale Implementation: Assist with QuickCode implementation to ensure proper setup, adoption, and a positive early customer experience
  • Post-Sale Implementation: Support the smooth transition of customers to the Clinical Success team
  • Internal & Market Collaboration: Share customer feedback and product enhancement ideas with the Product team
  • Internal & Market Collaboration: Work with Marketing on campaigns, messaging, and collateral to drive QuickCode adoption
  • Internal & Market Collaboration: Represent QuickCode at regional and national industry events
Desired Qualifications
  • Advanced knowledge of radiation oncology billing codes and related processes
  • 3+ years of sales experience in radiation oncology
  • Experience educating medical staff on coding and billing best practices
  • Familiarity with R&V, OIS, and EMR systems and their billing implications
  • Experience managing and communicating with enterprise-level organizations

Radformation provides FDA-cleared software tools for radiation therapy treatment planning to help clinics improve quality and efficiency. Its product suite includes ClearCheck for automated plan checks and documentation, ClearCalc for independent dose validation, EZFluence for generating 3D treatment plans, AutoContour an AI-driven contouring tool, ChartCheck for real-time patient data monitoring, and QuickCode for billing QA. These tools integrate into existing clinical workflows and are offered via software licenses with support services. Compared to competitors, Radformation offers a cohesive, FDA-cleared, multi-tool platform that covers plan checks, dose validation, plan generation, AI-assisted contouring, data monitoring, and billing QA in one ecosystem. The company’s goal is to streamline the entire treatment planning process, helping radiation oncology departments save time and resources while ensuring accurate, high-quality patient care.

Company Size

51-200

Company Stage

Early VC

Total Funding

$9.2M

Headquarters

New York City, New York

Founded

2016

Simplify Jobs

Simplify's Take

What believers are saying

  • Limbus AI acquisition expands AI contouring to serve 2,000 global clinics.
  • Icon Group deploys ChartCheck Adaptive across 15 Australian centers since November.
  • Regulatory clearances in Australia, Brazil, Canada, Thailand boost international sales.

What critics are saying

  • Varian's ARIA Eclipse AI tools lock clinics into ecosystems within 12-24 months.
  • MIM Software's superior AI contouring causes AutoContour customer churn in 6-12 months.
  • RaySearch RayStation native automation halves addressable market in 18-36 months.

What makes Radformation unique

  • Radformation offers vendor-neutral automation integrating with Eclipse, RayStation, and Monaco TPS.
  • FDA-cleared suite includes AutoContour AI contouring, EZFluence 3D planning, and ClearCheck checks.
  • Founders' physicist backgrounds drive error reduction in radiation therapy workflows since 2016.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Parental Leave

Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

13%
Business Wire
Feb 18th, 2026
Icon Group deploys ChartCheck Adaptive across 15 Australian cancer centres as Radformation gains US FDA 510(k) clearance

Icon Group has deployed ChartCheck Adaptive, Radformation's offline adaptive assessment solution, across 15 cancer centres in Australia. The rollout began in November and will expand to all Icon Cancer Centre locations globally in the coming months. The technology provides automated, quantitative insight into daily treatment delivery, particularly benefiting head and neck cancer cases. Early results show several patients were successfully re-planned due to anatomical changes during treatment, supporting clinical decision-making whilst maintaining efficient workflows. Radformation has secured expanded US FDA 510(k) clearance for ChartCheck to support the new adaptive functionality. The software evaluates daily imaging and treatment data to assess how dose and anatomy change throughout treatment. Icon Group, serving over 55 cancer centres globally, has partnered with Radformation as an early adopter and Centre of Excellence member.

Radformation
Jan 7th, 2025
Upcoming Release: AutoContour v2.6 Offers 95 Brand New Structure Models

Radformation is thrilled to announce the upcoming release of AutoContour v2.6, packed with exciting features, enhancements, and additional structure models.

Business Wire
May 3rd, 2024
Radformation to Accelerate AI-Based Solutions with Limbus AI Acquisition

Radformation, Inc. has acquired Limbus AI. This merger combines their strengths to advance AI-driven solutions, aiming to enhance patient care.

Business Wire
May 1st, 2024
Radformation Acquires Limbus AI

Radformation, a leader in cancer care automation, has acquired Limbus AI, a top provider of automated contouring software for radiation therapy. This merger enhances Radformation's AI capabilities and aims to integrate the best features of both companies' technologies, promising advancements in radiation therapy. The combined entity will now serve over 2,000 clinics globally, impacting 500,000 patients. This strategic move is set to drive innovation and improve patient outcomes in healthcare technology.

Business Wire
Feb 22nd, 2024
Radformation Recebe Autorizações Regulatórias Para Soluções De Automação Na Austrália, Brasil, Canadá E Tailândia

NOVA YORK--(BUSINESS WIRE)--Radformation, líder em soluções de software clínico e operacional para tratamento do câncer, anunciou hoje que recebeu autorizações regulatórias para suas soluções de automação de radioterapia* da Therapeutic Goods Administration (TGA) na Austrália, da Agência Nacional de Vigilância Sanitária (ANVISA) no Brasil, da Health Canada no Canadá e da Administração de Alimentos e Medicamentos (FDA) na Tailândia. “Essas autorizações refletem nosso compromisso com a inovação global em saúde e nossa dedicação em atender aos rigorosos padrões regulatórios essenciais para melhorar o atendimento aos pacientes no mundo inteiro”, disse Kurt Sysock, CEO da Radformation. Incluído nessas autorizações está o AutoContour, a solução de segmentação e perfilamento automática baseada em IA da Radformation, projetado para iniciar o processo de planejamento do tratamento. Em um estudo de caso recente, o AutoContour demonstrou diminuir o tempo de planejamento do perfilamento em uma média de 84% em todos os locais anatômicos, gerando perfilamentos altamente precisos, levando a uma melhor consistência do plano de tratamento. Os primeiros usuários brasileiros do AutoContour e do ClearCheck, o software automatizado de verificação de plano secundário da Radformation, a Liga Catarinense de Combate ao Câncer - Radioterapia São Sebastião e o Real Hospital Português de Beneficência, selecionaram as ferramentas da Radformation para complementar suas crescentes modalidades de tratamento de última geração e expandir a carga de pacientes

INACTIVE